AU6608600A - In vivo methods for the identification of target specific binding molecules in a human and their use in cancer detection - Google Patents

In vivo methods for the identification of target specific binding molecules in a human and their use in cancer detection

Info

Publication number
AU6608600A
AU6608600A AU66086/00A AU6608600A AU6608600A AU 6608600 A AU6608600 A AU 6608600A AU 66086/00 A AU66086/00 A AU 66086/00A AU 6608600 A AU6608600 A AU 6608600A AU 6608600 A AU6608600 A AU 6608600A
Authority
AU
Australia
Prior art keywords
identification
human
specific binding
binding molecules
target specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66086/00A
Inventor
David N. Krag
Lyn Oligino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERMONT AND STATE AGRICULTURAL COLLEGE THE, University of
Original Assignee
University of Vermont
University of Vermont and State Agricultural College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Vermont, University of Vermont and State Agricultural College filed Critical University of Vermont
Publication of AU6608600A publication Critical patent/AU6608600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU66086/00A 1999-07-29 2000-07-26 In vivo methods for the identification of target specific binding molecules in a human and their use in cancer detection Abandoned AU6608600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36422899A 1999-07-29 1999-07-29
US09/364228 1999-07-29
PCT/US2000/020273 WO2001009611A2 (en) 1999-07-29 2000-07-26 An vivo identification of specific binding molecules for cancer detection

Publications (1)

Publication Number Publication Date
AU6608600A true AU6608600A (en) 2001-02-19

Family

ID=23433598

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66086/00A Abandoned AU6608600A (en) 1999-07-29 2000-07-26 In vivo methods for the identification of target specific binding molecules in a human and their use in cancer detection

Country Status (2)

Country Link
AU (1) AU6608600A (en)
WO (1) WO2001009611A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
WO2003072542A2 (en) 2001-11-20 2003-09-04 Duke University Interfacial biomaterials
DE10224338A1 (en) * 2002-05-29 2003-12-24 Gerald-F Gerlach Means and methods for the enrichment and detection of microorganisms
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214B1 (en) * 1978-07-07 1985-10-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells
AU4412297A (en) * 1996-09-10 1998-04-02 Burnham Institute, The Tumor homing molecules, conjugates derived therefrom, and methods of using sa me

Also Published As

Publication number Publication date
WO2001009611A2 (en) 2001-02-08
WO2001009611A3 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU6754900A (en) Spectroscopic systems and methods for detecting tissue properties
HUP0201757A2 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
AU3395900A (en) Human lung cancer associated gene sequences and polypeptides
AU2001251348A1 (en) Apparatus for sensing human prostate tumor
EP1319178A4 (en) Method of identifying cancer markers and uses therefor in the diagnosis of cancer
AU2001286902A1 (en) Patient analysis and risk reduction system and associated methods
AU5135300A (en) Personal luggage identification system and methods for use
AU2723701A (en) Methods for identification and verification
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
AU2002223743A1 (en) Means for detecting pathological transformation of the APP protein and their uses
AU6608600A (en) In vivo methods for the identification of target specific binding molecules in a human and their use in cancer detection
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU2002248213A1 (en) Markers for disease susceptibility and targets for therapy
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
AU7089800A (en) 29 human cancer associated proteins
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU5140400A (en) Assay for the detection of paclitaxel resistant cells in human tumors
IL144287A0 (en) Dna molecules encoding human clax proteins and their soluble fusion proteins
IL132531A0 (en) Detection and therapy of tumors
AU5319400A (en) Molecules for disease detection and treatment
AU2351699A (en) The human calcium-sensing receptor in the detection and treatment of cancer
AU1464399A (en) Reagent for tumor therapy and/or imaging
AU6727598A (en) In vitro determination for detection of tumors of the intestine
AU6845600A (en) Method for identifying an individual at risk for vascular and cancer disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase